Mostra i principali dati dell'item
Endophthalmitis in HIV Infection
dc.creator | Tsirouki T., Steffen J., Dastiridou A., Praidou A., Androudi S. | en |
dc.date.accessioned | 2023-01-31T10:16:18Z | |
dc.date.available | 2023-01-31T10:16:18Z | |
dc.date.issued | 2020 | |
dc.identifier | 10.1080/09273948.2019.1699580 | |
dc.identifier.issn | 09273948 | |
dc.identifier.uri | http://hdl.handle.net/11615/80048 | |
dc.description.abstract | Purpose: The role of HIV infection in exogenous and endogenous endophthalmitis has not been clarified. We aim to assess the potential role of HIV as a risk factor or a poor prognostic feature in this sight-threatening condition. Methods: Literature review. Review of evidence: Evidence for endophthalmitis in HIV patients is based on scarce retrospective case series and case reports. Infrequency of literature on this topic is owed to the diversity of the different types of endophthalmitis as well as the rarity of the coexistence of the two conditions. Conclusions: Endophthalmitis in HIV patients are a rare but potentially devastating condition. Many forms of endophthalmitis tend to occur in severely immunosuppressed HIV patients with low CD4 counts. Therefore, the early introduction of cART with full immune reconstitution is an essential part of the prevention of endophthalmitis in the HIV population. © 2019 Taylor & Francis Group, LLC. | en |
dc.language.iso | en | en |
dc.source | Ocular Immunology and Inflammation | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078019038&doi=10.1080%2f09273948.2019.1699580&partnerID=40&md5=58e52a01eff9fa21ee6d7e3ca77a588b | |
dc.subject | ganciclovir | en |
dc.subject | antiinfective agent | en |
dc.subject | Aspergillus | en |
dc.subject | bacterial endogenous endophthalmitis | en |
dc.subject | Candida | en |
dc.subject | case study | en |
dc.subject | cataract | en |
dc.subject | disease association | en |
dc.subject | endogenous endophthalmitis | en |
dc.subject | endophthalmitis | en |
dc.subject | fungal endogenous endophthalmitis | en |
dc.subject | fungal endophthalmitis | en |
dc.subject | fungus | en |
dc.subject | human | en |
dc.subject | Human immunodeficiency virus infected patient | en |
dc.subject | Human immunodeficiency virus infection | en |
dc.subject | keratitis | en |
dc.subject | Klebsiella pneumoniae | en |
dc.subject | methicillin resistant Staphylococcus aureus | en |
dc.subject | Mycobacterium tuberculosis | en |
dc.subject | nonhuman | en |
dc.subject | prognosis | en |
dc.subject | retrospective study | en |
dc.subject | Review | en |
dc.subject | risk factor | en |
dc.subject | Salmonella enterica | en |
dc.subject | bacterial eye infection | en |
dc.subject | complication | en |
dc.subject | endophthalmitis | en |
dc.subject | fungal eye infection | en |
dc.subject | Human immunodeficiency virus infection | en |
dc.subject | Anti-Bacterial Agents | en |
dc.subject | Endophthalmitis | en |
dc.subject | Eye Infections, Bacterial | en |
dc.subject | Eye Infections, Fungal | en |
dc.subject | HIV Infections | en |
dc.subject | Humans | en |
dc.subject | Retrospective Studies | en |
dc.subject | Risk Factors | en |
dc.subject | Taylor and Francis Ltd. | en |
dc.title | Endophthalmitis in HIV Infection | en |
dc.type | other | en |
Files in questo item
Files | Dimensione | Formato | Mostra |
---|---|---|---|
Nessun files in questo item. |